Kaminski K - Search Results

1

Light-Controlled Anticancer Activity and Cellular Uptake of a Photoswitchable Cisplatin Analogue.

Stolarek M, Kaminski K, Kaczor-Kamińska M, Obłoza M, Bonarek P, Czaja A, Datta M, Łach W, Brela M, Sikorski A, Rak J, Nowakowska M, Szczubiałka K. Stolarek M, et al. Among authors: kaminski k. J Med Chem. 2024 Nov 14;67(21):19103-19120. doi: 10.1021/acs.jmedchem.4c01575. Epub 2024 Oct 24. J Med Chem. 2024. PMID: 39445571 Free PMC article.

2

pH-sensitive genipin-cross-linked chitosan microspheres for heparin removal.

Kamiński K, Zazakowny K, Szczubiałka K, Nowakowska M. Kamiński K, et al. Biomacromolecules. 2008 Nov;9(11):3127-32. doi: 10.1021/bm800724q. Epub 2008 Oct 23. Biomacromolecules. 2008. PMID: 18942790

3

Chitosan derivatives as novel potential heparin reversal agents.

Kamiński K, Szczubiałka K, Zazakowny K, Lach R, Nowakowska M. Kamiński K, et al. J Med Chem. 2010 May 27;53(10):4141-7. doi: 10.1021/jm1001666. J Med Chem. 2010. PMID: 20423087

4

Cationic derivatives of dextran and hydroxypropylcellulose as novel potential heparin antagonists.

Kamiński K, Płonka M, Ciejka J, Szczubiałka K, Nowakowska M, Lorkowska B, Korbut R, Lach R. Kamiński K, et al. J Med Chem. 2011 Oct 13;54(19):6586-96. doi: 10.1021/jm200380w. Epub 2011 Sep 6. J Med Chem. 2011. PMID: 21866887

5

Heparin--a key drug in the treatment of the circulatory degenerative diseases: controlling its action with polymers.

Szczubiałka K, Kamiński K, Zasada K, Karewicz A, Nowakowska M. Szczubiałka K, et al. Among authors: kaminski k. Curr Pharm Des. 2012;18(18):2591-606. doi: 10.2174/138161212800492840. Curr Pharm Des. 2012. PMID: 22512445 Review.

6

Cationic derivative of dextran reverses anticoagulant activity of unfractionated heparin in animal models of arterial and venous thrombosis.

Kalaska B, Sokolowska E, Kaminski K, Szczubialka K, Kramkowski K, Mogielnicki A, Nowakowska M, Buczko W. Kalaska B, et al. Among authors: kaminski k. Eur J Pharmacol. 2012 Jul 5;686(1-3):81-9. doi: 10.1016/j.ejphar.2012.04.037. Epub 2012 May 2. Eur J Pharmacol. 2012. PMID: 22579410

7

Novel polymeric inhibitors of HCoV-NL63.

Milewska A, Ciejka J, Kaminski K, Karewicz A, Bielska D, Zeglen S, Karolak W, Nowakowska M, Potempa J, Bosch BJ, Pyrc K, Szczubialka K. Milewska A, et al. Among authors: kaminski k. Antiviral Res. 2013 Feb;97(2):112-21. doi: 10.1016/j.antiviral.2012.11.006. Epub 2012 Nov 29. Antiviral Res. 2013. PMID: 23201315 Free PMC article.

8

The current view on biological potency of cationically modified chitosan.

Stefan J, Lorkowska-Zawicka B, Kaminski K, Szczubialka K, Nowakowska M, Korbut R. Stefan J, et al. Among authors: kaminski k. J Physiol Pharmacol. 2014 Jun;65(3):341-7. J Physiol Pharmacol. 2014. PMID: 24930505 Free article. Review.

9

Inactivation of heparin by cationically modified chitosan.

Lorkowska-Zawicka B, Kamiński K, Ciejka J, Szczubiałka K, Białas M, Okoń K, Adamek D, Nowakowska M, Jawień J, Olszanecki R, Korbut R. Lorkowska-Zawicka B, et al. Among authors: kaminski k. Mar Drugs. 2014 Jun 30;12(7):3953-69. doi: 10.3390/md12073953. Mar Drugs. 2014. PMID: 24983639 Free PMC article.

10

Enhanced delivery of daidzein into fibroblasts and neuronal cells with cationic derivatives of gamma-cyclodextrin for the control of cellular glycosaminoglycans.

Kamiński K, Kujdowicz M, Kajta M, Nowakowska M, Szczubiałka K. Kamiński K, et al. Eur J Pharm Biopharm. 2015 Apr;91:111-9. doi: 10.1016/j.ejpb.2015.02.002. Epub 2015 Feb 12. Eur J Pharm Biopharm. 2015. PMID: 25681746

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

616 results

Search Page

Filters